Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
  • Home
Article
  • Cited by 6

  • Get access
    Add to cart £25.00
    Check if you have access via personal or institutional login
    Log in Register

The point-touch technique for botulinum toxin injection in adductor spasmodic dysphonia: quality of life assessment

  • S Morzaria (a1) and E J Damrose (a1)

Abstract

Background:

Botulinum toxin injection under electromyographic guidance is the ‘gold standard’ for adductor spasmodic dysphonia treatment. The point-touch technique, an alternative injection method which relies on anatomical landmarks, is cheaper, quicker and more accessible, but has not yet gained widespread acceptance due to concerns about patient satisfaction.

Objective:

To assess swallowing and voice-related quality of life following point-touch botulinum toxin injection in adductor spasmodic dysphonia patients.

Setting:

Stanford University Voice and Swallowing Center.

Design:

Prospective case series (evidence level four).

Methods:

Consecutive adductor spasmodic dysphonia patients with a stable botulinum toxin dose–response relationship were recruited prospectively. The Eating Assessment Tool and Voice-Related Quality of Life questionnaires were completed pre-treatment and at 10 and 30 per cent completion of the injection cycle, respectively.

Results:

Thirty-seven patients completed follow up. The mean total botulinum toxin dose was 0.88 units. Pre-treatment Voice-Related Quality of Life questionnaire results reflected the burden of disease. Post-treatment Eating Assessment Tool and Voice-Related Quality of Life questionnaire results were collected at 2.53 and 7.84 weeks, respectively; the former showed an increase in dysphagia, albeit statistically insignificant, while the latter showed significantly improved scores (both domain and total).

Conclusion:

The point-touch technique is a viable alternative for botulinum toxin injection in the treatment of adductor spasmodic dysphonia.

Copyright

COPYRIGHT: © JLO (1984) Limited 2011

Corresponding author

Address for correspondence: Dr Sanjay Morzaria, Clinical Instructor, University of British Columbia, Department of Otolaryngology-Head and Neck Surgery, 103–8556 120th Street, Surrey, BC V3W 3N5, Canada Fax: (778) 565 3249, E-mail: Morzaria@yahoo.com

Footnotes

Hide All

Presented at the Canadian Society of Otolaryngology – Head and Neck Surgery Meeting, 23–26 May 2010, Niagara Falls, Ontario, Canada

Footnotes

References

Hide All
1Sulica, L. Contemporary management of spasmodic dysphonia. Curr Opin Otolaryngol Head Neck Surg 2004;12:543–8
2Blitzer, A, Brin, MF, Stewart, CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998;108:1435–41
3Watts, C, Nye, C, Whurr, R. Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review. Clin Rehabil 2006;20:112–22
4Chang, C, Chabot, P, Walz, CM. A survey of current practices of physicians who treat adductor spasmodic dysphonia in the U.S. Ear Nose Throat J 2009;88:E18
5Rodriquez, A, Ford, C, Bless, D, Harmon, R. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection. Electromyogr Clin Neurophysiol 1994;34:403–7
6Woo, P. Laryngeal electromyography is a cost-effective clinically useful tool in the evaluation of vocal fold function. Arch Otolaryngol Head Neck Surg 1998;124:472–6
7Casserly, P, Timon, C. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia. J Laryngol Otol 2008;122:52–6
8Woodson, G. Clinical value of laryngeal EMG is dependent on experience of the clinician. Arch Otolaryngol Head Neck Surg 1998;124:476
9Rhew, K, Fiedler, DA, Ludlow, CL. Technique for injection of botulinum toxin through a flexible nasolaryngoscope. Otolaryngol Head Neck Surg 1994;111:787–94
10Ford, C, Bless, DM, Lowery, JD. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia. Otolaryngol Head Neck Surg 1990;103:752–8
11Green, D, Berke, GS, Ward, PH, Gerratt, BR. Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia. Ann Otol Rhinol Laryngol 1992;101:883–7
12Blitzer, A, Brin, MF, Fahn, S, Lovelace, RE. Clinical and laboratory characteristics of laryngeal dystonia: a study of 110 cases. Laryngoscope 1988;98:636–40
13Paniello, R, Barlow, J, Serna, JS. Longitudinal follow-up of adductor spasmodic dysphonia patients after botulinum toxin injection: quality of life results. Laryngoscope 2008;118:564–8
14Hogikyan, N, Sethuraman, G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice 1999;13:557–69
15Morzaria, S, Damrose, EJ. A comparison of the VHI, VHI-10 and V-RQOL for measuring the effect of Botox therapy in adductor spasmodic dysphonia. J Voice 2010; Oct 15 [epub ahead of print]
16Rubin, A, Wodchis, WP, Spak, C, Kileny, PR, Hogikyan, ND. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II. Arch Otolaryngol Head Neck Surg 2004;130:415–20
17Paniello, R, Edgar, JD, Perlmutter, JS. Vocal exercise versus voice rest following botulinum toxin injections: a randomized crossover trial. Ann Otol Rhinol Laryngol 2009;118:759–63
18Hogikyan, N, Wodchis, WP, Spak, C, Kileny, PR. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia. J Voice 2001;15:576–86
19Braden, M, Johns, MM 3rd, Klein, AM, Delgaudio, JM, Gilman, M, Hapner, ER. Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception. J Voice 2010;24:242–9
20Hogikyan, ND, Wodchis, WP, Terrell, JE, Bradford, CR, Esclamado, RM. Voice-related quality of life (V-RQOL) following type I thyroplasty for unilateral vocal fold paralysis. J Voice 2000;14:378–86
21Belafsky, P, Mouadeb, DA, Rees, CJ, Pryor, JC, Postma, GN, Allen, J et al. Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol 2008;117:919–24

Keywords

  • Cited by 6

  • Get access
    Add to cart £25.00
    Check if you have access via personal or institutional login
    Log in Register

The point-touch technique for botulinum toxin injection in adductor spasmodic dysphonia: quality of life assessment

  • S Morzaria (a1) and E J Damrose (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed